Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of myeloperoxidase (MPO) inhibitors or pharmaceutically acceptable salts thereof to treat multiple system atrophy (MSA) 938

Use of myeloperoxidase (MPO) inhibitors or pharmaceutically acceptable salts thereof to treat multiple system atrophy (MSA) 938

US Patent 10772890 · Granted Sep 15, 2020

Estimated economic value: $184,920,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of rasagiline for the treatment of multiple system atrophy2014
Adjustment device for the adjustment of belts of belt conveyors2013
Operation and maintenance link for antenna equipment2000
Use of hydrophobic zeolites, syringe and method for removing of preservatives fr1999
Water dispersible and water soluble carbohydrate polymer compositions for parent1995
Water dispersible and water soluble carbohydrate polymer compositions for parent1993
Method of using zeolites for adsorbing detergents1992